Cocaine Effects in Humans: Physiology and Behavior - 1

  • Tell a FriendPrint

The purpose of this study is to compare the effects of buprenorphine or methadone maintenance on cocaine taking and on the physiological and subjective effects of cocaine, including cocaine craving, in opiate-dependent cocaine users...

Brief Summary

Official Title: “Cocaine Effects in Humans: Physiology and Behavior”

The purpose of this study is to compare the effects of buprenorphine or methadone maintenance on cocaine taking and on the physiological and subjective effects of cocaine, including cocaine craving, in opiate-dependent cocaine users.

  • Study Type: Interventional
  • Study Design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Caregiver), Primary Purpose: Treatment
  • Study Primary Completion Date: January 1998

Intervention(s) in this Clinical Trial

  • Drug: Methadone
    • normal maintenance dose

Outcome Measures for this Clinical Trial

Primary Measures

  • Interaction of cocaine and meds on cardio
    • Time Frame: 3 hr
      Safety Issue?: Yes
  • Interaction of cocaine & meds on coc's subjective
    • Time Frame: 3 hr
      Safety Issue?: Yes
  • Effects of medication on cocaine craving
    • Time Frame: 3 hr
      Safety Issue?: No

Criteria for Participation in this Clinical Trial

  • Please contact site for information.

Gender Eligibility for this Clinical Trial: Both

Minimum Age for this Clinical Trial: 18 Years

Maximum Age for this Clinical Trial: 45 Years

Are Healthy Volunteers Accepted for this Clinical Trial?: No

Clinical Trial Investigator Information

Lead Investigator: National Institute on Drug Abuse (NIDA) NIH

Overall Clinical Trial Officials and Contacts

Marian Fischman, Ph.D. Principal Investigator Columbia University  

Related Publications

Citations Reporting Results

Foltin RW, Fischman MW. Effects of methadone or buprenorphine maintenance on the subjective and reinforcing effects of intravenous cocaine in humans. J Pharmacol Exp Ther. 1996 Sep;278(3):1153-64.

Additional Information

Information obtained from ClinicalTrials.gov on February 12, 2012

Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00000200

Study ID Number: NIDA-03818-1

ClinicalTrials.gov Identifier: NCT00000200

Health Authority: United States: Federal Government

  • Tell a FriendPrint

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is:
http://clinicaltrialsfeeds.org/clinical-trials/show/NCT00000200